HRS-2543

N/A

Report date: 2024/08/04 20:00:06
NME

Base Information

Drug NameHRS-2543
Drug Alias NameHRS2543片HRS-2543HRS2543
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase; ERK1/ERK2 inhibitors
TargetsMitogen-activated protein kinase; ERK1/ERK2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Hengrui Pharmaceutical Co LtdJiangsu Hengrui Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A